Tryp Therapeutics Inc. 8FW.F Stock
Tryp Therapeutics Inc. Price Chart
Tryp Therapeutics Inc. 8FW.F Financial and Trading Overview
| Tryp Therapeutics Inc. stock price | 0.01 EUR |
| Previous Close | 0.05 EUR |
| Open | 0.05 EUR |
| Bid | 0.05 EUR x N/A |
| Ask | 0.06 EUR x N/A |
| Day's Range | 0.05 - 0.05 EUR |
| 52 Week Range | 0.02 - 0.16 EUR |
| Volume | 16K EUR |
| Avg. Volume | 2.4K EUR |
| Market Cap | 7.04M EUR |
| Beta (5Y Monthly) | -1.068614 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8FW.F Valuation Measures
| Enterprise Value | 3.43M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Tryp Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | -1.068614 |
| 52-Week Change | -15.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.16 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.04 EUR |
| 200-Day Moving Average | 0.07 EUR |
8FW.F Share Statistics
| Avg. Volume (3 month) | 2.4K EUR |
| Avg. Daily Volume (10-Days) | 4.77K EUR |
| Shares Outstanding | 96.42M |
| Float | 45.25M |
| Short Ratio | N/A |
| % Held by Insiders | 47.24% |
| % Held by Institutions | 0.042% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -237.49% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -5840681 EUR |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 43.84K EUR |
| Total Cash Per Share (mrq) | 0 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.17 |
| Book Value Per Share (mrq) | -0.016 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3584748 EUR |
| Levered Free Cash Flow (ttm) | -1446238 EUR |
Profile of Tryp Therapeutics Inc.
| Country | Germany |
| State | BC |
| City | Kelowna |
| Address | 301 - 1665 Ellis Street |
| ZIP | V1Y 2B3 |
| Phone | N/A |
| Website | https://www.tryptherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Tryp Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing psilocybin-related molecules. The company's Psilocybin-For-Neuropsychiatric Disorders (PFN) program focuses on the development of synthetic psilocybin-related molecules as a new class of drug for the treatment of binge eating, chronic pain, and other indications. Its program candidate includes TRP-8803, a psilocybin-based drug product for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Q&A For Tryp Therapeutics Inc. Stock
What is a current 8FW.F stock price?
Tryp Therapeutics Inc. 8FW.F stock price today per share is 0.01 EUR.
How to purchase Tryp Therapeutics Inc. stock?
You can buy 8FW.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tryp Therapeutics Inc.?
The stock symbol or ticker of Tryp Therapeutics Inc. is 8FW.F.
Which industry does the Tryp Therapeutics Inc. company belong to?
The Tryp Therapeutics Inc. industry is Biotechnology.
How many shares does Tryp Therapeutics Inc. have in circulation?
The max supply of Tryp Therapeutics Inc. shares is 226.45M.
What is Tryp Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
Tryp Therapeutics Inc. PE Ratio is now.
What was Tryp Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
Tryp Therapeutics Inc. EPS is -0.03 EUR over the trailing 12 months.
Which sector does the Tryp Therapeutics Inc. company belong to?
The Tryp Therapeutics Inc. sector is Healthcare.